.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Cerilliant
Dow
Johnson and Johnson
Daiichi Sankyo
Teva
Harvard Business School
US Department of Justice
UBS
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

Ethinyl estradiol; norelgestromin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethinyl estradiol; norelgestromin and what is the scope of ethinyl estradiol; norelgestromin freedom to operate?

Ethinyl estradiol; norelgestromin
is the generic ingredient in two branded drugs marketed by Janssen Pharms and Mylan Technologies, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norelgestromin. Two suppliers are listed for this compound.

Summary for ethinyl estradiol; norelgestromin

Pharmacology for ethinyl estradiol; norelgestromin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan TechnologiesXULANEethinyl estradiol; norelgestrominFILM, EXTENDED RELEASE;TRANSDERMAL200910-001Apr 16, 2014ABRXNoYes► Subscribe► Subscribe► Subscribe
Janssen PharmsORTHO EVRAethinyl estradiol; norelgestrominFILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 2001DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ethinyl estradiol; norelgestromin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen PharmsORTHO EVRAethinyl estradiol; norelgestrominFILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 2001► Subscribe► Subscribe
Janssen PharmsORTHO EVRAethinyl estradiol; norelgestrominFILM, EXTENDED RELEASE;TRANSDERMAL021180-001Nov 20, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Harvard Business School
Daiichi Sankyo
QuintilesIMS
McKinsey
McKesson
Queensland Health
Medtronic
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot